The OGT levels were also analyzed as prognostic factors and it was observed that disease-free survival 5 years post-treatment for prostate cancer was higher in patients with a low OGT expression profile compared with patients with increased OGT expression (26). This evidence concerns the gene OGT and prostate cancer.